UCLA Downtown Los Angeles Primary & Specialty Care — Los Angeles, California

UCLA Downtown Los Angeles Primary & Specialty Care is a clinical research site located in Los Angeles, California, United States 90017.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Downtown Los Angeles Primary & Specialty Care has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Downtown Los Angeles Primary & Specialty Care?

UCLA Downtown Los Angeles Primary & Specialty Care has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Downtown Los Angeles Primary & Specialty Care conducted?

UCLA Downtown Los Angeles Primary & Specialty Care has 2 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma.

Is UCLA Downtown Los Angeles Primary & Specialty Care accredited by Crixeo Health?

UCLA Downtown Los Angeles Primary & Specialty Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Downtown Los Angeles Primary & Specialty Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.